Condition
Immune Health
Your immune system is a network of white blood cells, antibodies, and signaling molecules that defend the body against germs, and it works less well when nutrients run short. Vitamin D and zinc have the strongest evidence behind them, while elderberry trials found colds lasted a shorter time and felt milder. That elderberry evidence is moderate and comes from small studies, and other compounds, like luteolin, have mostly been tested in lab work.
Sources: PMID 30670267
- Supplements studied
- 55
- Medicines and peptides
- 1
- Graded outcomes
- 54
- Trials
- 123
- People studied
- 19,979
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Moderate Decrease | Improves (the measure goes down) | Moderate effect | 3 studies | 178 people | ||
Studies that measured c-reactive protein (crp)
| ||||||
| Blood glucose No effect | NoneNo effect | 90 people | ||||
| Estrogen | Changes; see studies | 1 study | 8 people | |||
Studies that measured estrogen | ||||||
| Testosterone | Improves (the measure goes up) | 1 study | 8 people | |||
Studies that measured testosterone | ||||||
| Triglycerides | Changes; see studies | 1 study | 90 people | |||
| Cortisol | Changes; see studies | 8 people | ||||
| DHT | Improves (the measure goes up) | 8 people | ||||
| Erythrocyte Sedimentation Rate | Changes; see studies | 80 people | ||||
| Free Testosterone | Improves (the measure goes up) | 8 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 90 people | ||||
| Inflammation | Changes; see studies | 8 people | ||||
| Interleukin 1-alpha | Improves (the measure goes up) | 80 people | ||||
| Interleukin 1-beta | Changes; see studies | 90 people | ||||
| Interleukin 6 | Changes; see studies | 170 people | ||||
| Low-density lipoprotein (LDL) | Changes; see studies | 90 people | ||||
| Monocyte Chemoattractant Protein-1 | Improves (the measure goes up) | 90 people | ||||
| Rheumatoid Arthritis Symptoms | Changes; see studies | 80 people | ||||
| TNF-Alpha | Changes; see studies | 80 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| CD4+ Count Significant increase in CD4+ counts; enhanced NK cell cytotoxicity (45%) | Improves (the measure goes up) | Moderate effect | 30 people |
Triphala (Emblica officinalis, Terminalia chebula, Terminalia bellirica)
- Antioxidant Status: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Antioxidant Status Phase I clinical study in healthy volunteers: Triphala supplementation significantly increased SOD activity and decreased MDA and protein carbonyl concentrations. Rich in vitamin C, gallic acid, ellagic acid, and flavonoids. Free radical-scavenging activity comparable to ascorbic acid. | Improves (the measure goes up) | Moderate effect |
Lactoferrin
- Inflammation Markers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Inflammation Markers Moderate Decrease | Improves (the measure goes down) | Moderate effect | 1,200 people |
Luteolin
- Mast Cell Inhibition: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Mast Cell Inhibition In vitro studies: Luteolin significantly more potent than cromolyn (standard mast cell stabilizer) at inhibiting release of histamine, tryptase, MMP-9, VEGF, IL-1β, IL-6, IL-8, and TNF from human mast cells. Effective at concentrations achievable with oral supplementation. | Improves (the measure goes up) | Large effect |
N-Acetylcysteine
- COPD Symptoms: improves
- Neutrophil Activity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| COPD Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 5 studies | 20 people | ||
Studies that measured copd symptoms
| ||||||
| Neutrophil Activity | Improves (the measure goes up) | 1 study | 50 people | |||
Studies that measured neutrophil activity | ||||||
Vitamin C
- Blood glucose: improves
- Upper Respiratory Tract Infection Symptoms: improves
- Cortisol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 3 studies | 28 people | ||
Studies that measured blood glucose
| ||||||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 24 studies | 474 people | |||
Studies that measured upper respiratory tract infection symptoms | ||||||
| Cortisol | Improves (the measure goes down) | 5 studies | 93 people | |||
Studies that measured cortisol | ||||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 5 studies | 56 people | |||
Studies that measured oxidative stress biomarkers
| ||||||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 5 studies | 1,159 people | |||
Studies that measured upper respiratory tract infection risk
| ||||||
| Exercise-Induced Oxidation | Changes; see studies | 2 studies | 16 people | |||
| Inflammation | Improves (the measure goes down) | 2 studies | 30 people | |||
| Muscle Damage | Changes; see studies | 2 studies | 30 people | |||
| Uric Acid | Improves (the measure goes down) | 2 studies | 28 people | |||
| Heart Rate | Improves (the measure goes down) | 1 study | 40 people | |||
| Interferon Gamma | Improves (the measure goes up) | 1 study | 28 people | |||
| Plasma Vitamin C | Improves (the measure goes up) | 1 study | 56 people | |||
| Exercise-Induced Immune Suppression | Improves (the measure goes up) | 93 people | ||||
| IL-1Ra | Improves (the measure goes down) | 28 people | ||||
| Insulin | Changes; see studies | 28 people | ||||
| Interleukin 10 | Improves (the measure goes up) | 28 people | ||||
| Interleukin 2 | Improves (the measure goes up) | 28 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 28 people | ||||
| Interleukin 8 | Changes; see studies | 28 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 28 people | ||||
| Monocyte Count | Improves (the measure goes up) | 28 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 28 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 28 people | ||||
Theanine
- Anxiety Symptoms: improves
- Heart Rate: improves
- Interleukin 4: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 12 people | ||
| Heart Rate | Improves (the measure goes down) | 1 study | 12 people | |||
| Interleukin 4 | Improves (the measure goes up) | 1 study | 20 people | |||
Studies that measured interleukin 4 | ||||||
| Stress Signs and Symptoms | Improves (the measure goes down) | 1 study | 12 people | |||
Studies that measured stress signs and symptoms | ||||||
| Granulocyte Count | Improves (the measure goes up) | 20 people | ||||
| Interferon Gamma | Improves (the measure goes up) | 20 people | ||||
| Interleukin 10 | Improves (the measure goes up) | 20 people | ||||
| Interleukin 2 | Improves (the measure goes up) | 20 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 20 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 20 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 20 people | ||||
| Treg Cells | Improves (the measure goes up) | 20 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 20 people | ||||
Cat's claw
- White Blood Cell Count: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| White Blood Cell Count Small Increase | Improves (the measure goes up) | Small effect | 1 study | 4 people | ||
Studies that measured white blood cell count | ||||||
Iodine
- C-Reactive Protein (CRP): improves
- Interleukin 6: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 30 people | ||
Studies that measured c-reactive protein (crp) | ||||||
| Interleukin 6 | Improves (the measure goes down) | 30 people | ||||
Reishi
- CD3 Lymphocytes: improves
- CD4 Lymphocytes: improves
- Immunity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| CD3 Lymphocytes Small Increase | Improves (the measure goes up) | Small effect | 1 study | 40 people | ||
Studies that measured cd3 lymphocytes | ||||||
| CD4 Lymphocytes Small Increase | Improves (the measure goes up) | Small effect | 40 people | |||
| Immunity | Improves (the measure goes up) | 3 studies | 97 people | |||
Studies that measured immunity
| ||||||
| Proteinuria | Improves (the measure goes up) | 1 study | 14 people | |||
| Natural Killer Cell Activity | Improves (the measure goes up) | 34 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 34 people | ||||
Glutathione
- Anti-Oxidant Enzyme Profile: improves
- Natural Killer Cell Activity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Moderate Increase | Improves (the measure goes up) | Moderate effect | 1 study | 52 people | ||
Studies that measured anti-oxidant enzyme profile | ||||||
| Natural Killer Cell Activity Small Increase | Improves (the measure goes up) | Small effect | 52 people | |||
Saffron
- Basophil Count: improves
- Blood glucose: improves
- Creatinine: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Basophil Count Small Decrease | Improves (the measure goes down) | Small effect | 89 people | |||
| Blood glucose | Improves (the measure goes down) | 6 studies | 64 people | |||
| Creatinine | Improves (the measure goes up) | 2 studies | 89 people | |||
| TNF-Alpha | Improves (the measure goes down) | 2 studies | 64 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 64 people | |||
| Liver Enzymes | Changes; see studies | 1 study | 89 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 64 people | |||
| Eosinophil count | Changes; see studies | 89 people | ||||
| HbA1c | Improves (the measure goes down) | 64 people | ||||
| Immunoglobulin A | Improves (the measure goes up) | 89 people | ||||
| Immunoglobulin G | Improves (the measure goes up) | 89 people | ||||
| Immunoglobulin M | Improves (the measure goes up) | 89 people | ||||
| Interleukin 10 | Improves (the measure goes up) | 64 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 64 people | ||||
| Monocyte Count | Improves (the measure goes up) | 89 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 89 people | ||||
| Red Blood Cell Count | Improves (the measure goes up) | 89 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 64 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 89 people |
Fish Oil
- 5-HEPE: improves
- Triglycerides: improves
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| 5-HEPE Moderate Increase | Improves (the measure goes up) | Moderate effect | 50 people | |||
| Triglycerides | Improves (the measure goes down) | 24 studies | 135 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 7 studies | 135 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 4 studies | 221 people | |||
| Inflammation | Improves (the measure goes down) | 4 studies | 276 people | |||
| Cortisol | Improves (the measure goes down) | 2 studies | 61 people | |||
| TNF-Alpha | Improves (the measure goes down) | 2 studies | 63 people | |||
| Vascular Function | Improves (the measure goes up) | 2 studies | 25 people | |||
| 5-HETE | Improves (the measure goes up) | 1 study | 50 people | |||
| Blood Flow | Improves (the measure goes up) | 1 study | 25 people | |||
| Exercise-Induced Immune Suppression | Improves (the measure goes up) | 1 study | 16 people | |||
| Interleukin 2 | Improves (the measure goes up) | 1 study | 16 people | |||
| Leukotriene B5 | Improves (the measure goes up) | 1 study | 50 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 1 study | 110 people | |||
| Natural Killer Cell Content | Improves (the measure goes up) | 1 study | 155 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 46 people | |||
| T Cell Count | Improves (the measure goes up) | 1 study | 185 people | |||
| B Cell Count | Improves (the measure goes up) | 139 people | ||||
| Leukotriene B4 | Improves (the measure goes up) | 50 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 25 people | ||||
| Natural Killer Cell Activity | Improves (the measure goes up) | 139 people | ||||
| Oxygen Uptake | Improves (the measure goes up) | 16 people |
Guduchi
- Allergy Symptoms: improves
- Eosinophil count: changes; see studies
- Lymphocyte Count: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Allergy Symptoms Large Improvement | Improves (the measure goes down) | Large effect | 75 people | |||
| Eosinophil count | Changes; see studies | 75 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 150 people | ||||
| Nasal Congestion | Improves (the measure goes up) | 75 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 75 people |
Lactobacillus Casei
- C-Reactive Protein (CRP): improves
- Blood glucose
- Immunoglobulin A: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Small Increase | Improves (the measure goes down) | Small effect | 28 people | |||
| Blood glucose No effect | NoneNo effect | 28 people | ||||
| Immunoglobulin A | Improves (the measure goes up) | 2 studies | 84 people | |||
| Intestinal Permeability | Improves (the measure goes up) | 1 study | 28 people | |||
| Immunity | Improves (the measure goes up) | 28 people | ||||
| Immunoglobulin G | Improves (the measure goes up) | 84 people | ||||
| Triglycerides | Improves (the measure goes down) | 28 people | ||||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 84 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 84 people |
Perilla
- C-Reactive Protein (CRP): improves
- Low-density lipoprotein (LDL): improves
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Moderate Decrease | Improves (the measure goes down) | Moderate effect | 36 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 1 study | 36 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 36 people | ||||
| Liver Enzymes | Changes; see studies | 36 people | ||||
| Plasminogen Inhibitor-1 | Improves (the measure goes up) | 36 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 36 people | ||||
| Triglycerides | Improves (the measure goes down) | 36 people |
Umckaloabo
- Exercise-Induced Immune Suppression: improves
- Immunoglobulin A: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Exercise-Induced Immune Suppression Small Improvement | Improves (the measure goes up) | Small effect | 25 people | |||
| Immunoglobulin A | Improves (the measure goes up) | 1 study | 25 people |
Vitamin D
- Body Fat: improves
- Upper Respiratory Tract Infection Risk: changes; see studies
- Upper Respiratory Tract Infection Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Small Decrease | Improves (the measure goes down) | Small effect | 165 people | |||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 13 studies | 152 people | |||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 13 studies | 68 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 3 studies | 165 people | |||
| Interleukin 5 | Improves (the measure goes up) | 1 study | 30 people | |||
| Parathyroid Hormone | Improves (the measure goes up) | 1 study | 165 people | |||
| Tuberculosis Symptoms | Improves (the measure goes down) | 1 study | 120 people | |||
| Metabolic Rate | Improves (the measure goes up) | 165 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 165 people | ||||
| Triglycerides | Improves (the measure goes down) | 165 people |
Ashwagandha
- Immunity: improves
- Natural Killer Cell Activity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Immunity Small Improvement | Improves (the measure goes up) | Small effect | 5 people | |||
| Natural Killer Cell Activity | Improves (the measure goes up) | 1 study | 5 people |
Echinacea
- Exercise-Induced Immune Suppression: improves
- Upper Respiratory Tract Infection Risk: changes; see studies
- Upper Respiratory Tract Infection Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Exercise-Induced Immune Suppression Small Improvement | Improves (the measure goes up) | Small effect | 32 people | |||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 10 studies | 32 people | |||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 1 study | 32 people |
Tulsi
- Immunity: improves
- Natural Killer Cell Content: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Immunity Small Improvement | Improves (the measure goes up) | Small effect | 24 people | |||
| Natural Killer Cell Content | Improves (the measure goes up) | 1 study | 24 people |
Spirulina
- Anti-Oxidant Enzyme Profile: improves
- Low-density lipoprotein (LDL): improves
- Interleukin 6: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 78 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 5 studies | 128 people | |||
| Interleukin 6 | Improves (the measure goes down) | 3 studies | 206 people | |||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 2 studies | 50 people | |||
| Blood glucose | Improves (the measure goes down) | 1 study | 50 people | |||
| Interleukin 4 | Improves (the measure goes up) | 1 study | 36 people | |||
| Natural Killer Cell Activity | Improves (the measure goes up) | 1 study | 21 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 78 people | |||
| Treg Cells | Improves (the measure goes up) | 1 study | 19 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 128 people | |||
| White Blood Cell Count | Improves (the measure goes up) | 1 study | 40 people | |||
| CD8 Lymphocytes | Improves (the measure goes up) | 19 people | ||||
| Complement Component 3 | Improves (the measure goes up) | 78 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 128 people | ||||
| Immunoglobulin A | Improves (the measure goes up) | 78 people | ||||
| Immunoglobulin G | Improves (the measure goes up) | 78 people | ||||
| Insulin | Changes; see studies | 50 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 50 people | ||||
| Interferon Gamma | Improves (the measure goes up) | 36 people | ||||
| Interleukin 2 | Improves (the measure goes up) | 114 people | ||||
| Monocyte Chemoattractant Protein-1 | Improves (the measure goes up) | 78 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 40 people | ||||
| Red Blood Cell Count | Improves (the measure goes up) | 40 people | ||||
| T Cell Count | Improves (the measure goes up) | 19 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 156 people |
L-Carnitine
- Blood Flow: improves
- Muscle Mass: improves
- Oxidative Stress Biomarkers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Small Increase | Improves (the measure goes up) | Small effect | 30 people | |||
| Muscle Mass | Improves (the measure goes up) | 3 studies | 75 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 3 studies | 75 people | |||
| TNF-Alpha | Improves (the measure goes down) | 2 studies | 30 people | |||
| Body Fat | Improves (the measure goes down) | 1 study | 75 people | |||
| Myeloperoxidase | Improves (the measure goes up) | 1 study | 75 people | |||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 75 people |
Black Ginger
- Anti-Oxidant Enzyme Profile: improves
- Functionality in Elderly or Injured: improves
- Oxidative Stress Biomarkers: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Moderate Increase | Improves (the measure goes up) | Moderate effect | 45 people | |||
| Functionality in Elderly or Injured | Improves (the measure goes up) | 1 study | 45 people | |||
| Oxidative Stress Biomarkers | Changes; see studies | 45 people |
Guduchi
- Allergy Symptoms: improves
- Lymphocyte Count: improves
- Eosinophil count: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Allergy Symptoms Large Improvement | Improves (the measure goes down) | Large effect | 75 people | |||
| Lymphocyte Count | Improves (the measure goes up) | 1 study | 150 people | |||
| Eosinophil count | Changes; see studies | 75 people | ||||
| Nasal Congestion | Improves (the measure goes up) | 75 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 75 people |
Curcumin
- Anti-Oxidant Enzyme Profile: improves
- Blood glucose: improves
- Triglycerides: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Moderate Increase | Improves (the measure goes up) | Moderate effect | 38 people | |||
| Blood glucose | Improves (the measure goes down) | 18 studies | 3,048 people | |||
| Triglycerides | Improves (the measure goes down) | 9 studies | 3,364 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 6 studies | 38 people | |||
| Liver Enzymes | Changes; see studies | 3 studies | 1,329 people | |||
| Interleukin 6 | Improves (the measure goes down) | 1 study | 1,005 people | |||
| Body Mass Index (BMI) | Improves (the measure goes down) | 2,789 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1,716 people | ||||
| Cell Adhesion Factors | Improves (the measure goes down) | 38 people | ||||
| HbA1c | Improves (the measure goes down) | 1,196 people | ||||
| Myeloperoxidase | Improves (the measure goes up) | 38 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 38 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 1,025 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 529 people |
Eleuthero
- Fat Oxidation: improves
- Heart Rate
- Natural Killer Cell Content: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fat Oxidation Small Increase | Improves (the measure goes up) | Small effect | 31 people | |||
| Heart Rate No effect | NoneNo effect | 1 study | 31 people | |||
| Natural Killer Cell Content | Improves (the measure goes up) | 1 study | 31 people | |||
| Immunity | Improves (the measure goes up) | 62 people | ||||
| Oxygen Uptake | Improves (the measure goes up) | 31 people |
Astaxanthin
- B Cell Count: worsens
- C-Reactive Protein (CRP): changes; see studies
- Oxidative Stress Biomarkers: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count Small Decrease | Worsens (the measure goes down) | Small effect | 42 people | |||
| C-Reactive Protein (CRP) | Changes; see studies | 5 studies | 82 people | |||
| Oxidative Stress Biomarkers | Changes; see studies | 3 studies | 40 people | |||
| Triglycerides | Changes; see studies | 2 studies | 69 people | |||
| Blood glucose | Changes; see studies | 1 study | 35 people | |||
| Eosinophil count | Changes; see studies | 1 study | 35 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 69 people | |||
| Inflammation | Changes; see studies | 1 study | 44 people | |||
| Liver Enzymes | Changes; see studies | 1 study | 104 people | |||
| Lymphocyte Count | Improves (the measure goes up) | 1 study | 64 people | |||
| Basophil Count | Improves (the measure goes up) | 35 people | ||||
| Bilirubin | Changes; see studies | 35 people | ||||
| DNA Damage | Changes; see studies | 71 people | ||||
| Estrogen | Changes; see studies | 29 people | ||||
| Fibrinogen | Improves (the measure goes up) | 29 people | ||||
| Hematocrit | Improves (the measure goes up) | 35 people | ||||
| Hemoglobin | Improves (the measure goes up) | 35 people | ||||
| Interferon Gamma | Improves (the measure goes up) | 42 people | ||||
| Interleukin 2 | Improves (the measure goes up) | 42 people | ||||
| Interleukin 6 | Changes; see studies | 42 people | ||||
| Low-density lipoprotein (LDL) | Changes; see studies | 69 people | ||||
| Monocyte Count | Improves (the measure goes up) | 35 people | ||||
| Muscle Damage | Changes; see studies | 35 people | ||||
| Natural Killer Cell Activity | Improves (the measure goes up) | 42 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 42 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 64 people | ||||
| Red Blood Cell Count | Improves (the measure goes up) | 35 people | ||||
| Serum Albumin | Improves (the measure goes up) | 35 people | ||||
| Serum Platelets | Improves (the measure goes up) | 35 people | ||||
| T Cell Count | Improves (the measure goes up) | 42 people | ||||
| TNF-Alpha | Changes; see studies | 42 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 69 people | ||||
| Uric Acid | Changes; see studies | 40 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 64 people |
Rose Hip
- C-Reactive Protein (CRP)
- Chemotaxis: changes; see studies
- Liver Enzymes: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 3 studies | 13 people | |||
| Chemotaxis | Changes; see studies | 13 people | ||||
| Liver Enzymes | Changes; see studies | 13 people |
King of Bitters
- CD4 Lymphocytes
- Early Virologic Response: improves
- Liver Enzymes: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| CD4 Lymphocytes No effect | NoneNo effect | 1 study | 34 people | |||
| Early Virologic Response | Improves (the measure goes up) | 17 people | ||||
| Liver Enzymes | Changes; see studies | 17 people |
Conjugated Linoleic Acid
- C-Reactive Protein (CRP)
- Inflammation: improves
- Interleukin 2: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 1 study | 63 people | |||
| Inflammation | Improves (the measure goes down) | 1 study | 61 people | |||
| Interleukin 2 | Improves (the measure goes up) | 1 study | 10 people | |||
| Cell Adhesion Factors | Improves (the measure goes down) | 53 people | ||||
| Crohn's Disease Symptoms | Improves (the measure goes down) | 10 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 10 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 63 people |
Docosahexaenoic Acid
- B Cell Count
- Inflammation: improves
- Natural Killer Cell Activity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count No effect | NoneNo effect | 1 study | 58 people | |||
| Inflammation | Improves (the measure goes down) | 12 people | ||||
| Natural Killer Cell Activity | Improves (the measure goes up) | 58 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 46 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 46 people | ||||
| T Cell Count | Improves (the measure goes up) | 58 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 12 people |
Hesperidin
- B Cell Count
- C-Reactive Protein (CRP): improves
- Neutrophil Count: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count No effect | NoneNo effect | 24 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 296 people | |||
| Neutrophil Count | Improves (the measure goes up) | 1 study | 24 people | |||
| Intercellular Adhesion Molecule 1 | Changes; see studies | 296 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 296 people | ||||
| Natural Killer Cell Activity | Improves (the measure goes up) | 24 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 24 people | ||||
| Neutrophil Activity | Improves (the measure goes up) | 24 people | ||||
| sE-Selectin | Improves (the measure goes up) | 296 people | ||||
| T Cell Count | Improves (the measure goes up) | 24 people | ||||
| Vascular Adhesion Protein-1 | Improves (the measure goes up) | 296 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 24 people |
Quercetin
- Interleukin 6
- Intestinal Permeability: improves
- Uric Acid: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Interleukin 6 No effect | NoneNo effect | 15 people | ||||
| Intestinal Permeability | Improves (the measure goes up) | 8 people | ||||
| Uric Acid | Improves (the measure goes down) | 15 people |
Tongkat Ali
- B Cell Count
- Neutrophil Count: improves
- CD4 Lymphocytes: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count No effect | NoneNo effect | 84 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 1 study | 84 people | |||
| CD4 Lymphocytes | Improves (the measure goes up) | 84 people | ||||
| CD8 Lymphocytes | Improves (the measure goes up) | 84 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 84 people | ||||
| Mood | Improves (the measure goes up) | 84 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 84 people | ||||
| T Cell Count | Improves (the measure goes up) | 84 people |
Tetradecyl Thioacetic Acid
- Blood glucose
- HbA1c: improves
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 18 people | ||||
| HbA1c | Improves (the measure goes down) | 1 study | 10 people | |||
| Heart Rate | Improves (the measure goes down) | 1 study | 18 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 18 people | ||||
| Glycemic Control | Improves (the measure goes up) | 10 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 28 people | ||||
| HIV Viral Load | Improves (the measure goes up) | 10 people | ||||
| Liver Enzymes | Changes; see studies | 28 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 28 people | ||||
| Red Blood Cell Count | Improves (the measure goes up) | 18 people | ||||
| Serum T4 | Improves (the measure goes up) | 18 people | ||||
| Thyroid-Stimulating Hormone | Improves (the measure goes up) | 18 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 10 people | ||||
| Triglycerides | Improves (the measure goes down) | 28 people | ||||
| Uric Acid | Improves (the measure goes down) | 18 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 18 people |
Vitamin E
- B Cell Count
- Oxidative Stress Biomarkers: improves
- Interferon Gamma: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count No effect | NoneNo effect | 53 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 3 studies | 32 people | |||
| Interferon Gamma | Improves (the measure goes up) | 2 studies | 322 people | |||
| CD8 Lymphocytes | Improves (the measure goes up) | 1 study | 53 people | |||
| Creatinine | Improves (the measure goes up) | 1 study | 32 people | |||
| Immunoglobulin G | Improves (the measure goes up) | 1 study | 140 people | |||
| Liver Enzymes | Changes; see studies | 1 study | 32 people | |||
| White Blood Cell Count | Improves (the measure goes up) | 1 study | 120 people | |||
| CD4 Lymphocytes | Improves (the measure goes up) | 53 people | ||||
| Immunity | Improves (the measure goes up) | 281 people | ||||
| Immunoglobulin A | Improves (the measure goes up) | 32 people | ||||
| Immunoglobulin M | Improves (the measure goes up) | 32 people | ||||
| Interleukin 2 | Improves (the measure goes up) | 193 people | ||||
| Interleukin 4 | Improves (the measure goes up) | 322 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 53 people | ||||
| Prostaglandin E2 | Improves (the measure goes down) | 32 people | ||||
| Red Blood Cell Count | Improves (the measure goes up) | 32 people | ||||
| Vaccine Augmentation | Improves (the measure goes up) | 196 people |
Chlorella
- Body Fat
- Immunity: improves
- Vaccine Augmentation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat No effect | NoneNo effect | 15 people | ||||
| Immunity | Improves (the measure goes up) | 1 study | 15 people | |||
| Vaccine Augmentation | Improves (the measure goes up) | 1 study | 117 people |
Citrulline
- DNA Damage
- Immunity: improves
- Liver Enzymes: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| DNA Damage No effect | NoneNo effect | 17 people | ||||
| Immunity | Improves (the measure goes up) | 1 study | 17 people | |||
| Liver Enzymes | Changes; see studies | 17 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 17 people |
Colostrum
- B Cell Count
- C-Reactive Protein (CRP)
- Upper Respiratory Tract Infection Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count No effect | NoneNo effect | 138 people | ||||
| C-Reactive Protein (CRP) No effect | NoneNo effect | 52 people | ||||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 4 studies | 78 people | |||
| Diarrhea Symptoms | Improves (the measure goes down) | 3 studies | 20 people | |||
| IGF-1 | Improves (the measure goes up) | 2 studies | 39 people | |||
| Intestinal Parasites | Improves (the measure goes up) | 2 studies | 20 people | |||
| CD4 Lymphocytes | Improves (the measure goes up) | 1 study | 138 people | |||
| Exercise-Induced Immune Suppression | Improves (the measure goes up) | 1 study | 9 people | |||
| Immunity | Improves (the measure goes up) | 1 study | 138 people | |||
| Immunoglobulin A | Improves (the measure goes up) | 1 study | 135 people | |||
| Immunoglobulin M | Improves (the measure goes up) | 1 study | 70 people | |||
| Natural Killer Cell Content | Improves (the measure goes up) | 1 study | 150 people | |||
| Neutrophil Count | Improves (the measure goes up) | 1 study | 9 people | |||
| Testosterone | Improves (the measure goes up) | 1 study | 9 people | |||
| CD8 Lymphocytes | Improves (the measure goes up) | 138 people | ||||
| Cortisol | Improves (the measure goes down) | 18 people | ||||
| Fat Oxidation | Improves (the measure goes up) | 9 people | ||||
| Growth Hormone | Improves (the measure goes up) | 9 people | ||||
| Immunoglobulin E | Improves (the measure goes up) | 9 people | ||||
| Immunoglobulin G | Improves (the measure goes up) | 100 people | ||||
| Interferon Gamma | Improves (the measure goes up) | 9 people | ||||
| Interleukin 1-alpha | Improves (the measure goes up) | 9 people | ||||
| Interleukin 10 | Improves (the measure goes up) | 9 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 9 people | ||||
| Interleukin 8 | Changes; see studies | 9 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 9 people | ||||
| Macrophage Activity | Improves (the measure goes up) | 12 people | ||||
| T Cell Count | Improves (the measure goes up) | 138 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 9 people | ||||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 78 people | ||||
| Vaccine Augmentation | Improves (the measure goes up) | 156 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 12 people |
Alpha-Linolenic Acid (ALA)
- B Cell Count
- Oxidative Stress Biomarkers: changes; see studies
- Natural Killer Cell Activity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count No effect on B cell count | NoneNo effect | 46 people | ||||
| Oxidative Stress Biomarkers | Changes; see studies | 1 study | 46 people | |||
| Natural Killer Cell Activity | Improves (the measure goes up) | 46 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 46 people | ||||
| T Cell Count | Improves (the measure goes up) | 46 people |
Panax Ginseng (Korean Ginseng)
- Adiponectin
- Immunoglobulin A: improves
- Fatigue Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 80 people | ||||
| Immunoglobulin A | Improves (the measure goes up) | 1 study | 38 people | |||
| Fatigue Symptoms | Improves (the measure goes down) | 80 people | ||||
| Liver Enzymes | Changes; see studies | 80 people | ||||
| Peak power output (PPO) | Improves (the measure goes up) | 38 people |
Cocoa Extract
- Adrenocorticotropic Hormone
- Fat Oxidation: improves
- Cortisol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenocorticotropic Hormone No effect | NoneNo effect | 14 people | ||||
| Fat Oxidation | Improves (the measure goes up) | 1 study | 14 people | |||
| Cortisol | Improves (the measure goes down) | 14 people | ||||
| Exercise-Induced Oxidation | Changes; see studies | 14 people | ||||
| Heart Rate | Improves (the measure goes down) | 14 people | ||||
| Insulin | Changes; see studies | 14 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 14 people | ||||
| Neutrophil Activity | Improves (the measure goes up) | 14 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 14 people |
Creatine
- Anti-Oxidant Enzyme Profile
- Muscle Damage: changes; see studies
- Creatinine: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile No effect | NoneNo effect | 25 people | ||||
| Muscle Damage | Changes; see studies | 4 studies | 50 people | |||
| Creatinine | Improves (the measure goes up) | 3 studies | 25 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 25 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 25 people | ||||
| Fatigue Symptoms | Improves (the measure goes down) | 25 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 25 people |
Lactobacillus reuteri
- B Cell Count
- Immunity: improves
- Immunoglobulin A: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count No effect | NoneNo effect | 31 people | ||||
| Immunity | Improves (the measure goes up) | 1 study | 31 people | |||
| Immunoglobulin A | Improves (the measure goes up) | 1 study | 23 people | |||
| Lymphocyte Count | Improves (the measure goes up) | 31 people | ||||
| Monocyte Count | Improves (the measure goes up) | 31 people |
Alpha-Lipoic Acid
- Oxidative Stress Biomarkers: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Oxidative Stress Biomarkers | Changes; see studies | 4 studies | 33 people |
Coenzyme Q10
- Inflammation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Inflammation | Improves (the measure goes down) | 2 studies | 20 people |
Glutamine
- Insulin: changes; see studies
- Immunity: improves
- Blood glucose: worsens
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Insulin | Changes; see studies | 2 studies | 33 people | |||
| Immunity | Improves (the measure goes up) | 1 study | 69 people | |||
| Blood glucose Small Detriment | Worsens (the measure goes up) | Small effect | 33 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 33 people | ||||
| Cortisol | Improves (the measure goes down) | 33 people | ||||
| Inflammation | Improves (the measure goes down) | 33 people | ||||
| Testosterone | Improves (the measure goes up) | 33 people |
DHEA
- Muscle Mass: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Muscle Mass | Improves (the measure goes up) | 2 studies | 40 people |
Zinc
- Upper Respiratory Tract Infection Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Upper Respiratory Tract Infection Risk | Changes; see studies | 1 study | 100 people |
Feverfew
- Erythema: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Erythema | Improves (the measure goes up) | 1 study | 8 people |
Pomegranate seed oil
- TNF-Alpha: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| TNF-Alpha | Improves (the measure goes down) | 1 study | 45 people |
Astragalus
- Immunity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Immunity | Improves (the measure goes up) | 1 study | 16 people |
Phlebodium aureum
- Upper Respiratory Tract Infection Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Upper Respiratory Tract Infection Risk | Changes; see studies | 116 people |
Prescription medicines and peptides studied, for context
KPV
- Pro-inflammatory Cytokine Reduction: changes; see studies
- Macrophage Activation Suppression: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Pro-inflammatory Cytokine Reduction Inhibition of TNF-α, IL-1β, and IL-6 secretion at nanomolar concentrations | Changes; see studies | Moderate effect | 70 studies | 90 people | ||
| Macrophage Activation Suppression Inhibition of LPS-induced cytokine synthesis and CD86 expression | Changes; see studies | Moderate effect | 69 studies | 60 people |
What the published studies found
12 automated readings
Citrulline: respiratory infections
Too few usable studies were found to tell whether Citrulline changes respiratory infections. 8 studies were read and none could be counted.
Elderberry: influenza
The best available review (2019, 180 people) found an improvement in influenza. 3 of the 4 studies read agree; 1 found no clear difference. The evidence is limited.
4 studies counted of 9 read: 1 review and 3 trials (147 people in the trials).
- Meta-analysis, 2019; 180 people: improves (the review the verdict rests on).
Supplementation with elderberry was found to substantially reduce upper respiratory symptoms. The quantitative synthesis of …
Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials - Randomised trial, 2020; 87 people; emergency room patients with influenza: no clear difference.
no evidence that elderberry benefits the duration
Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial - Randomised trial, 2004; 60 people; patients with influenza-like symptoms: improves.
Symptoms were relieved on average 4 days earlier
Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections - Randomised trial, 1995; individuals in agricultural community during outbreak: improves. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama
- Meta-analysis, 2019; 180 people: improves (the review the verdict rests on).
Fish Oil: respiratory infections
The best available review (2018) found little or no difference in respiratory infections. All 2 studies read agree. The evidence is limited.
2 studies counted of 10 read: 2 reviews.
- Meta-analysis, 2018: no clear difference (the review the verdict rests on).
did not reveal any differences, neither in infections rates
Intravenous fish oil in critically ill and surgical patients - Historical remarks and critical appraisal - Meta-analysis, 2014; 6 studies, 390 people: no clear difference.
no effect on infections (RR, 0.76
Parenteral fish oil lipid emulsions in the critically ill: a systematic review and meta-analysis
- Meta-analysis, 2018: no clear difference (the review the verdict rests on).
Multivitamin: respiratory infections
The studies disagree. The best available review (2006, 20 studies) did not settle it for respiratory infections, while 1 of the 2 studies read found no clear answer. The evidence is very weak.
2 studies counted of 10 read: 2 reviews.
- Meta-analysis, 2006; 20 studies: mixed results (the review the verdict rests on).
significantly less episodes of infection in those supplemented
A systematic review of multivitamin and multimineral supplementation for infection - Meta-analysis, 2005; 8 studies; elderly people: unclear: evidence too weak to tell. Role of multivitamins and mineral supplements in preventing infections in elderly people: systematic review and meta-analysis of randomised controlled trials
- Meta-analysis, 2006; 20 studies: mixed results (the review the verdict rests on).
Panax Ginseng (Korean Ginseng): respiratory infections
The best available review (2021, 39 studies, 16,797 people) found an improvement in respiratory infections. 3 of the 7 studies read agree; 2 found no clear answer, 2 found no clear difference. The evidence is moderate.
7 studies counted of 11 read: 3 reviews and 4 trials (1,582 people in the trials).
- Systematic review, 2021; 39 studies, 16,797 people: improves (the review the verdict rests on). Effects of select dietary supplements on the prevention and treatment of viral respiratory tract infections: a systematic review of randomized controlled trials
- Meta-analysis, 2020; 10 studies; healthy adults: unclear: evidence too weak to tell.
significant effect on SAURIs incidence (RR = 0.69
Ginseng integrative supplementation for seasonal acute upper respiratory infections: A systematic review and meta-analysis - Systematic review, 2011; 5 studies, 747 people; healthy adults: unclear: evidence too weak to tell.
tendency toward a lower incidence of having at least one common cold
North American (Panax quinquefolius) and Asian Ginseng (Panax ginseng) Preparations for Prevention of the Common Cold in Healthy Adults: A Systematic Review - Randomised trial, 2012; 293 people; patients with early-stage, untreated chronic lymphocytic leukemia: no clear difference.
no significant differences of the 2 a priori primary end points
A randomized, controlled trial of Panax quinquefolius extract (CVT-E002) to reduce respiratory infection in patients with chronic lymphocytic leukemia - Randomised trial, 2011; 783 people; influenza-vaccinated community-dwelling adults: no clear difference.
incidence of LCCUs in the ITT group was 5.5%, 5.2%, and 4.6%
Efficacy and Safety of CVT-E002, a Proprietary Extract of Panax quinquefolius in the Prevention of Respiratory Infections in Influenza-Vaccinated Community-Dwelling Adults: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial - Randomised trial, 2005; 279 people; adults with history of at least 2 colds: improves.
mean number of colds per person was lower
Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial - Randomised trial, 1996; 227 people; 227 volunteers visiting private practices in Milan: improves.
frequency of influenza or common cold between weeks 4 and 12 was 42 cases in …
Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]
Probiotics: respiratory infections
A Cochrane review (2022, 24 studies, 6,950 people) found a small improvement in respiratory infections. That review studied people of all ages at risk of acute URTIs. 6 of the 7 studies read agree; 1 found no clear answer. The evidence is limited.
7 studies counted of 10 read: 6 reviews and 1 trial (120 people in the trials).
- Systematic review, 2022; 24 studies, 6,950 people; people of all ages at risk of acute URTIs: improves (the review the verdict rests on).
probiotics may reduce the number of participants diagnosed with URTIs
Probiotics for preventing acute upper respiratory tract infections - Systematic review, 2026; 8 studies, 1,158 people; children with respiratory tract infections: improves. Comparative efficacy and safety of probiotic for respiratory tract infections in children: a network meta-analysis
- Meta-analysis, 2026; 32 studies; patients with upper respiratory tract infections: unclear: evidence too weak to tell.
pooled incidence reduction was non-significant (RD = -0.07
The Efficacy of Probiotics in Treating Upper Respiratory Tract Infections, Allergic Rhinitis, and Chronic Rhinosinusitis: A Systematic Review and Meta-Analysis - Meta-analysis, 2025; 13 studies; patients with respiratory diseases: improves.
significantly reduced the incidence of respiratory disease episodes
Role of Lacticaseibacillus rhamnosus GG in the Management of Respiratory Diseases: A Systematic Review and Meta-Analysis - Meta-analysis, 2019; 17 studies, 3,488 people; children aged up to 18 years: improves. Probiotics for preventing acute otitis media in children
- Meta-analysis, 2014; 8 studies, 1,083 people; ICU patients receiving mechanical ventilation: improves.
use of probiotics decreased the incidence of VAP
Probiotics for preventing ventilator-associated pneumonia - Randomised trial, 2026; 120 people; children with recurrent respiratory tract infections: improves.
Probiotics significantly improved clinical efficacy compared with placebo
Probiotic modulation of gut microbiota with Bifidobacterium animalis subsp. lactis XLTG11 and Lactobacillus plantarum CCFM8661 mitigates recurrent respiratory infections in children: a randomised-controlled trial
- Systematic review, 2022; 24 studies, 6,950 people; people of all ages at risk of acute URTIs: improves (the review the verdict rests on).
Saffron: respiratory infections
Too few usable studies were found to tell whether Saffron changes respiratory infections. 4 studies were read and none could be counted.
Selenium: respiratory infections
The studies read are too weak to tell whether Selenium changes respiratory infections. The strongest review read studied critically ill adults. The evidence is very weak.
6 studies counted of 11 read: 4 reviews and 2 trials (159 people in the trials).
- Meta-analysis, 2015; 16 studies, 2,084 people; critically ill adults: unclear: evidence too weak to tell (the review the verdict rests on). Selenium supplementation for critically ill adults
- Systematic review, 2020; 43 studies; humans with viral and respiratory infections: improves.
selenium and zinc have also shown favourable immune-modulatory effects
Enhancing immunity in viral infections, with special emphasis on COVID-19: A review - Meta-analysis, 2019; 13 studies; patients with sepsis syndrome: no clear difference.
incidence of renal failure, secondary infection or duration
A meta-analysis of randomized controlled trials: Efficacy of selenium treatment for sepsis - Meta-analysis, 2016; 21 studies: no clear difference.
no significant treatment effect of parenteral Se
High-dose intravenous selenium does not improve clinical outcomes in the critically ill: a systematic review and meta-analysis - Randomised trial, 2025; 60 people; hospitalised under-five children with acute lower respiratory tract infections: improves.
reduces the need for mechanical ventilation
Oral Selenium as an Adjunct in the Treatment of Acute Lower Respiratory Tract Infections in Children: A Double-Blind Randomized Controlled Trial - Randomised trial, 2018; 99 people: no clear difference.
The incidence of VAP was 19.4/1000days of mechanical ventilation in the placebo group while it …
Antioxidant reserve of the lungs and ventilator-associated pneumonia: A clinical trial of high dose selenium in critically ill patients
Vitamin C: respiratory infections
A Cochrane review (2013, 29 studies, 11,306 people) found little or no difference in respiratory infections. 1 of the 3 studies read agree; 1 found an improvement, 1 found no clear answer. The evidence is moderate.
3 studies counted of 6 read: 3 reviews.
- Meta-analysis, 2013; 29 studies, 11,306 people: no clear difference (the review the verdict rests on).
pooled RR was 0.97 (95% confidence interval (CI) 0.94 to 1.00)
Vitamin C for preventing and treating the common cold - Meta-analysis, 2022; 10 studies: improves.
shorter duration of respiratory infection (SMD -0.36
Effect of Vitamin C Supplements on Respiratory Tract Infections: A Systematic Review and Meta-Analysis - Meta-analysis, 2013; 6 studies, 2,532 people: unclear: evidence too weak to tell.
statistically significant (80% or greater) reduction in pneumonia incidence
Vitamin C for preventing and treating pneumonia
- Meta-analysis, 2013; 29 studies, 11,306 people: no clear difference (the review the verdict rests on).
Vitamin D: respiratory infections
A Cochrane review (2026, 107 studies, 31,521 people) found a small improvement in respiratory infections. That review studied children up to five years of age. 5 of the 8 studies read agree; 2 found no clear difference, 1 found no clear answer. The evidence is limited.
8 studies counted of 10 read: 5 reviews and 3 trials (540 people in the trials).
- Meta-analysis, 2026; 107 studies, 31,521 people; children up to five years of age: improves (the review the verdict rests on).
slight reduction in the proportion of children who make ARI-related healthcare visits
Vitamin D for preventing acute respiratory infections in children up to five years of age - Meta-analysis, 2025; 40 studies, 61,589 people: no clear difference.
did not statistically significantly affect overall ARI risk
Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data - Meta-analysis, 2025; 37 studies, 16,000 people: unclear: evidence too weak to tell.
SOR was 0.92 (0.86-0.99) for all trials
Vitamin D, acute respiratory infections, and Covid-19: The curse of small-size randomised trials. A critical review with meta-analysis of randomised trials - Systematic review, 2025; 38 studies; offspring of mothers given vitamin D in pregnancy: improves.
vitamin D supplementation reduced respiratory tract infections
Effects of Maternal Vitamin D Supplementation on Childhood Health - Meta-analysis, 2016; 4 studies, 3,198 people; children under five years of age: no clear difference.
episodes of 'radiologically confirmed' first or only episode of pneumonia were little different
Vitamin D supplementation for preventing infections in children under five years of age - Randomised trial, 2026; 80 people; ICU patients with traumatic lung contusion, VAP, sepsis: improves.
faster recovery from lung contusion, VAP, and sepsis
Effect of vitamin D as Nutrition Supplement on Patients with Prolonged Ventilation due to Ventilator Associated Pneumonia and Sepsis Followed Severe Traumatic Lung Contusion: A Randomized Controlled Trial - Randomised trial, 2025; 200 people; healthy 6-8-year-old children: improves.
had 17% fewer sick days due to ARTI
Effects of vitamin D supplementation on acute respiratory tract infections in 6-8-year-old children: a randomized clinical trial - Randomised trial, 2015; 260 people; pregnant women and their infants: improves.
proportion of children making any ARI visits was smaller in the higher-dose
Reduced primary care respiratory infection visits following pregnancy and infancy vitamin D supplementation: a randomised controlled trial
- Meta-analysis, 2026; 107 studies, 31,521 people; children up to five years of age: improves (the review the verdict rests on).
Vitamin E: respiratory infections
The 2 studies read (29,633 people in all) mostly found little or no difference in respiratory infections. The evidence is limited.
2 studies counted of 10 read: 2 trials (29,633 people in the trials).
- Randomised trial, 2010; 500 people; elderly nursing home residents: unclear: evidence too weak to tell.
effect of vitamin E on lower RI depended on sex
IL-2 and IL-10 gene polymorphisms are associated with respiratory tract infection and may modulate the effect of vitamin E on lower respiratory tract infections in elderly nursing home residents - Randomised trial, 2004; 29,133 people; male smokers aged 50 to 69 years: no clear difference. Vitamin E and beta-carotene supplementation and hospital-treated pneumonia incidence in male smokers
- Randomised trial, 2010; 500 people; elderly nursing home residents: unclear: evidence too weak to tell.
Zinc: respiratory infections
A Cochrane review (2024, 34 studies, 8,526 people) found little or no difference in respiratory infections. That review studied children and adults with or at risk of common cold. 3 of the 6 studies read agree; 3 found an improvement. The evidence is limited.
6 studies counted of 8 read: 6 reviews.
- Systematic review, 2024; 34 studies, 8,526 people; children and adults with or at risk of common cold: no clear difference (the review the verdict rests on).
little or no reduction in the risk of developing a cold
Zinc for prevention and treatment of the common cold - Systematic review, 2026; 19 studies, 11,576 people; children under 18 years old: no clear difference.
Direct comparison meta-analysis showed no statistically significant differences between low-dose vitamin D, vitamin A, vitamin …
Comparative efficacy of nutritional supplements for the prevention of respiratory tract infections in children: a systematic review and network meta-analysis - Systematic review, 2026; children with respiratory infections: improves.
reducing the incidence and burden of respiratory infections
The Role of Zinc in Pediatric Respiratory Infections: Evidence from Clinical Trials and Real-World Studies - Meta-analysis, 2022; 14 studies, 9,940 people; preterm or low birth weight infants: no clear difference.
no effect on acute respiratory infections
Enteral Zinc Supplementation in Preterm or Low Birth Weight Infants: A Systematic Review and Meta-analysis - Meta-analysis, 2016; 6 studies, 5,193 people; children aged 2 months to 59 months: improves. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
- Meta-analysis, 2013; 18 studies, 1,781 people; healthy people with common cold symptoms: improves.
The incidence rate ratio (IRR) of developing a cold (IRR 0.64, 95% CI 0.47 to …
Zinc for the common cold
- Systematic review, 2024; 34 studies, 8,526 people; children and adults with or at risk of common cold: no clear difference (the review the verdict rests on).
Key findings
- C-Reactive Protein (CRP)Improves (the measure goes down)
- CD4+ CountImproves (the measure goes up)
- Antioxidant StatusImproves (the measure goes up)
The Immune Health & Function protocol
2 primary supplements · 2 supporting supplements
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
The supplements graded A or B for Immune Health. Each opens third-party tested products for that supplement.
- Grade B
- Grade B
- Grade B
- Grade B
- Grade B
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
7 studies from PubMed
- Double-blinded randomized controlled trial for immunomodulatory effects of Tulsi (Ocimum sanctum Linn.) leaf extract on healthy volunteers
- Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer
- Systemic production of IFN-alpha by garlic (Allium sativum) in humans
- Effect of plant-based diets on obesity-related inflammatory profiles: a systematic review and meta-analysis of intervention trials
- Effects of Dietary Patterns on Biomarkers of Inflammation and Immune Responses: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- The influence of resistance training on inflammatory markers, body composition and functional capacity in healthy older adults: A systematic review and meta-analysis.
- Regular consumption of concord grape juice benefits human immunity